On Tuesday, Tyra Biosciences Inc (NASDAQ: TYRA) opened lower -6.24% from the last session, before settling in for the closing price of $9.30. Price fluctuations for TYRA have ranged from $9.05 to $29.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -42.22% at the time writing. With a float of $30.76 million, this company’s outstanding shares have now reached $50.75 million.
The extent of productivity of a business whose workforce counts for 60 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tyra Biosciences Inc (TYRA) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tyra Biosciences Inc is 39.40%, while institutional ownership is 62.60%. The most recent insider transaction that took place on Feb 05 ’25, was worth 74,324. In this transaction Director of this company sold 5,401 shares at a rate of $13.76, taking the stock ownership to the 443,885 shares. Before that another transaction happened on Feb 05 ’25, when Company’s Director proposed sale 120,000 for $13.75, making the entire transaction worth $1,650,000.
Tyra Biosciences Inc (TYRA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -42.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -19.96% during the next five years compared to -73.69% drop over the previous five years of trading.
Tyra Biosciences Inc (NASDAQ: TYRA) Trading Performance Indicators
Check out the current performance indicators for Tyra Biosciences Inc (TYRA). In the past quarter, the stock posted a quick ratio of 23.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -2.31 in one year’s time.
Technical Analysis of Tyra Biosciences Inc (TYRA)
The latest stats from [Tyra Biosciences Inc, TYRA] show that its last 5-days average volume of 0.34 million was superior to 0.29 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 8.73%. Additionally, its Average True Range was 0.79.
During the past 100 days, Tyra Biosciences Inc’s (TYRA) raw stochastic average was set at 0.66%, which indicates a significant decrease from 1.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.72% in the past 14 days, which was higher than the 51.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.24, while its 200-day Moving Average is $17.40. Now, the first resistance to watch is $9.20. This is followed by the second major resistance level at $9.68. The third major resistance level sits at $9.95. If the price goes on to break the first support level at $8.45, it is likely to go to the next support level at $8.18. Assuming the price breaks the second support level, the third support level stands at $7.70.
Tyra Biosciences Inc (NASDAQ: TYRA) Key Stats
There are currently 53,090K shares outstanding in the company with a market cap of 462.94 million. Presently, the company’s annual sales total 0 K according to its annual income of -86,480 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -25,570 K.
